News and Events

News, events, white papers, reports and videos

VIDEO

OncoHealth Launches First Digital Telehealth Service for People with Cancer

Collaborates with Three Innovative Health Plans to Deliver Personalized Supportive Care

Categories
ISPOR 2023

Impacting Innovation, Value, and Healthcare Decision Making
May 7-10, 2023
Boston, MA

Iris Oncology - Screens

Oncology Nursing Team Will Highlight Digital Health Platform Iris’ Benefits to Cancer Patients

Wesley Staggs - CCO

Executive to Lead Sales, Partnerships, Business Development to Drive OncoHealth Growth

APOS 2023

Psychosocial Oncology Conference
March 15-17, 2023
Portland, Oregon

Hallie Strong Foundation

Bethany Hart wants to share her story to help others feel less alone and create a legacy for the baby she lost.

Susan Hoang

Former McKesson Executive to Enhance Organizational Analytics and Data Strategy

OncoHealth To Present at the 2022 San Antonio Breast Cancer Symposium on Off-Label Trastuzumab Deruxtecan and Use in Breast Cancer Brain Metastases

OncoHealth®, a leading digital health company dedicated to oncology, will present the results of its latest real-world data research on trastuzumab deruxtecan (T-DXd) for the treatment of breast cancer on December 8 at the 2022 San Antonio Breast Cancer Symposium (SABCS)

DIA-2022

Real-World Evidence Conference
November 10-11, 2022
San Diego, CA

37th Annual Meeting & Pre-Conference Programs
November 10-12, 2022
Boston, MA
Booth #740

October 19-21, 2022
New York, NY

October 11-14, 2022
National Harbor, MD
Booth #311

Three Oncology Studies from ASCO that Health Plans Should Pay Attention to Now

OncoHealth highlights three impactful studies and what Payers need to know to effectively manage oncology drugs and expand off-label access.

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from OncoHealth.

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from OncoHealth.

You have Successfully Subscribed!